A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
about
Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacyDiagnosis and management of the primary headache disorders in the emergency department settingManagement of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies.Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.Migraine: pharmacotherapy in the emergency departmentProviding relief from headache pain. Current options for acute and prophylactic therapy.The clinician's approach to the management of headache.Neurogenic inflammation in the context of migraine.Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium.Acute Migraine Treatment in Adults.Pharmacologic treatment of migraine. Comparison of guidelines.Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons.Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.The pharmacological management of migraine, part 1: overview and abortive therapy.Migraine, allodynia, and implications for treatment.Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department.What happens to the old headache medicines?Acute treatment of migraines.MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine.Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine.Relatively slow and long-lasting antimigraine effect of dihydroergotamine is most likely due to basic pharmacological attributes of the drug: a review.Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings.Treatment of acute migraine in the emergency department.Inhaled drug therapy development for the treatment of migraine.MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.Emergency management of migraine: is the headache really over?Revisiting the role of ergots in the treatment of migraine and headache.Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial.Cost considerations of acute migraine treatment.Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo.Le traitement de la migraine aiguë à l’urgence.Post-traumatic Headache.Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat.Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.
P2860
Q24321991-EB3FDC02-4F9D-43A1-B496-DBA196D3B0A1Q24651176-084274C5-41DD-4305-B538-DB82A6E79C59Q30389259-1F461093-47D9-404B-B8E5-8D7F5EE7D088Q30584718-C99A6432-ECEB-4F39-94CC-38E40906F3E0Q34032129-5AE044BF-B9D2-42B8-92B7-60C536F67E85Q34044773-5923472F-555F-47C9-BEFA-259B463E2170Q34187950-0D5EA5A9-19ED-45D9-A6CD-76F02B1F920DQ34218309-FAC700B3-132B-4082-9221-4B8E632EDEDEQ34243951-C7D43854-DD5A-441C-9CED-752FC8038C97Q34471863-0A91ADAC-B45F-4F34-9A19-BB3DA31E115DQ34682941-E29EEF74-3AEC-434E-B736-3ACB0043B682Q35026810-62149AD8-F3A3-4EAE-BB1F-B4776E5EE538Q35110498-13DAAA91-657F-4D10-B73C-7EB78A3F852FQ36641562-455F3DE2-5A8E-466A-A310-94430C2CFD10Q37155841-0DE2786E-4DB8-4ED0-9250-502ED1BA4BBBQ37340160-6EE008C5-915B-44A4-89B1-0304E619629BQ37345140-3810D6E4-23D8-40C7-AF33-6C37895FB7B3Q37589659-64EB6563-553B-4186-88D5-398021A32821Q38001056-6E5CA78F-C220-40CC-A634-99388A39424AQ38028610-EE8673D8-093C-4F63-B339-8481FE5DC703Q38031885-17988DA0-B68A-4C13-A6D6-EA00E3C0E2F2Q38066258-E3F45597-20E5-4CAC-AA3B-6E636AE6F843Q38099236-686460C9-CDFA-484A-B74F-9C48D2F6F877Q38101880-A1CB6D7A-60EA-4823-AF96-B80FD770E255Q38215960-5728DD9B-A17B-4F01-9CF4-49BABECC533BQ38879331-CCA5885D-4F31-4F1E-BC0B-0CF8EDF10C28Q38896569-6CD8C661-A26B-4893-A631-CB5EE42EAC42Q39268172-05537B43-3BFE-4AA5-B239-289255FA58E3Q39301943-4B60670C-CF3F-484F-9928-FABB7DE47478Q39338402-03E5A9A5-426F-4311-AE5F-3973D4753D97Q39443442-C81FFC5E-01B1-4FB7-BF1D-7F34C0C81B2DQ39444676-C9F84CCB-1C06-406B-88BD-D310679A14B2Q43114702-B5190A52-0758-45D8-8CD2-A4D58CEC8C22Q44287731-AF32DBD2-923E-4E53-8BE3-BDFF7EDD9DBEQ44794053-B8D52651-ABD2-49EB-8BFA-904C14E22CC3Q46580205-BD30AAB6-515F-4BED-890D-A2D3F3A6B1C9Q46633266-E9551F37-37AC-414F-B92C-3E8159A2D111Q48677565-484EA524-1069-440E-BB30-6BEE49DE9CE3Q48715691-00F58DF5-531A-4014-AFE2-362996E7860FQ49873285-E799FA53-0AD7-43E7-9BC7-C9D4ED09EDD2
P2860
A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A double-blind study of subcut ...... e treatment of acute migraine.
@en
A double-blind study of subcut ...... e treatment of acute migraine.
@nl
type
label
A double-blind study of subcut ...... e treatment of acute migraine.
@en
A double-blind study of subcut ...... e treatment of acute migraine.
@nl
prefLabel
A double-blind study of subcut ...... e treatment of acute migraine.
@en
A double-blind study of subcut ...... e treatment of acute migraine.
@nl
P2093
P1433
P1476
A double-blind study of subcut ...... e treatment of acute migraine.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1996.00550020092020
P577
1996-02-01T00:00:00Z